Fresenius Medical Care (NYSE:FMS) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Fresenius Medical Care (NYSE:FMS) in a research report report published on Thursday morning. The brokerage issued a strong-buy rating on the stock.

Several other research firms also recently commented on FMS. Berenberg Bank assumed coverage on shares of Fresenius Medical Care in a research report on Wednesday, November 6th. They issued a “buy” rating and a $25.60 price target for the company. Truist Financial increased their target price on shares of Fresenius Medical Care from $22.00 to $23.00 and gave the stock a “hold” rating in a research note on Monday, October 7th.

Fresenius Medical Care Price Performance

Shares of NYSE FMS opened at $22.02 on Thursday. The stock has a market cap of $12.92 billion, a P/E ratio of 18.20, a P/E/G ratio of 1.01 and a beta of 0.91. Fresenius Medical Care has a twelve month low of $17.93 and a twelve month high of $22.76. The stock has a 50 day moving average of $20.97 and a two-hundred day moving average of $20.30. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42.

Institutional Investors Weigh In On Fresenius Medical Care

Hedge funds have recently modified their holdings of the stock. Allworth Financial LP raised its position in Fresenius Medical Care by 53.1% during the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock worth $36,000 after buying an additional 581 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new position in Fresenius Medical Care during the third quarter worth about $38,000. GAMMA Investing LLC raised its holdings in Fresenius Medical Care by 50.4% during the third quarter. GAMMA Investing LLC now owns 4,998 shares of the company’s stock worth $106,000 after purchasing an additional 1,675 shares in the last quarter. ORG Wealth Partners LLC acquired a new stake in Fresenius Medical Care in the third quarter valued at about $112,000. Finally, Venturi Wealth Management LLC boosted its holdings in Fresenius Medical Care by 1,045.8% in the 3rd quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company’s stock valued at $112,000 after purchasing an additional 4,800 shares in the last quarter. 8.25% of the stock is owned by institutional investors and hedge funds.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.